Overview Cardiac Electrophysiological Study Status: Completed Trial end date: 2008-06-01 Target enrollment: Participant gender: Summary The purpose of the study is to measure the effects of AZD1305 on cardiac electrophysiological properties and intracardiac pressures Phase: Phase 2 Details Lead Sponsor: AstraZeneca